Blurbs

Analysts Are Neutral on Top Healthcare Stocks: Sanofi (SNYNF), Zymeworks (ZYME)

Analysts fell to the sidelines weighing in on Sanofi (SNYNFResearch Report), Zymeworks (ZYMEResearch Report) and Twist Bioscience (TWSTResearch Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.

Sanofi (SNYNF)

UBS analyst Michael Leuchten maintained a Hold rating on Sanofi today and set a price target of EUR92.00. The company’s shares closed last Friday at $87.60.

According to TipRanks.com, Leuchten is ranked #2204 out of 8112 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sanofi with a $104.32 average price target.

See the top stocks recommended by analysts >>

Zymeworks (ZYME)

H.C. Wainwright analyst Robert Burns reiterated a Hold rating on Zymeworks today and set a price target of $10.00. The company’s shares closed last Friday at $7.76.

According to TipRanks.com, Burns has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -24.1% and a 22.7% success rate. Burns covers the Healthcare sector, focusing on stocks such as Springworks Therapeutics, Neoleukin Therapeutics, and Allogene Therapeutics.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Zymeworks with a $12.17 average price target, representing a 51.9% upside. In a report issued on November 9, SVB Securities also maintained a Hold rating on the stock with a $8.00 price target.

Twist Bioscience (TWST)

SVB Securities analyst Puneet Souda maintained a Hold rating on Twist Bioscience today and set a price target of $30.00. The company’s shares closed last Friday at $24.81, close to its 52-week low of $23.90.

According to TipRanks.com, Souda has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -10.6% and a 38.3% success rate. Souda covers the Healthcare sector, focusing on stocks such as AbCellera Biologics, Castle Biosciences, and Myriad Genetics.

The word on The Street in general, suggests a Hold analyst consensus rating for Twist Bioscience with a $36.25 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on SNYNF:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More